Univ of California / San Diego Treatment Ctr — San Diego, California

Univ of California / San Diego Treatment Ctr is a clinical research site located in San Diego, California, United States 921036325.

Crixeo Clinical Trials Trust Score: 28/100 (FAILING). This profile has not yet been claimed by the site owner.

Univ of California / San Diego Treatment Ctr has participated in 60 clinical trials.

Therapeutic areas: HIV Infections, Meningitis, Cryptococcal, Mycobacterium Avium-Intracellulare Infection.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), G D Searle, Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in San Diego

Browse all research sites in California · View every site in San Diego

Sponsor Feasibility Report

Trust Score: 28/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Univ of California / San Diego Treatment Ctr?

Univ of California / San Diego Treatment Ctr has a Crixeo Trust Score of 28/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Univ of California / San Diego Treatment Ctr conducted?

Univ of California / San Diego Treatment Ctr has 60 clinical trials on record. Their work covers HIV Infections, Meningitis, Cryptococcal, Mycobacterium Avium-Intracellulare Infection.

Is Univ of California / San Diego Treatment Ctr accredited by Crixeo Clinical Trials?

Univ of California / San Diego Treatment Ctr has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Univ of California / San Diego Treatment Ctr?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.